Consideración de los mejores diseños de estudio para evaluar las intervenciones sanitarias

Ramírez-Sevilla C, Gómez-Lanza E, Puyol-Pallàs J-M. Behavior of MV140 vaccine to prevent recurrent urinary tract infections in patients with metabolic syndrome and smoking. Revista Mexicana de Urología. 2022;82(6):1–8. doi: https://doi.org/10.48193/revistamexicanadeurologa.v82i6.959

He Q, Wang Z, Liu G, Daneshgari F, MacLennan GT, Gupta S. Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links. Prostate Cancer Prostatic Dis. 2016;19(1):7–13. doi: https://doi.org/10.1038/pcan.2015.43

Dobrowolski P, Prejbisz A, Kuryłowicz A, Baska A, Burchardt P, Chlebus K, et al. Metabolic syndrome – a new definition and management guidelines. A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons. Arch Med Sci. 2022;18(5):1133–56. doi: https://doi.org/10.5114/aoms/152921

Clarke GM, Conti S, Wolters AT, Steventon A. Evaluating the impact of healthcare interventions using routine data. BMJ. 2019;365:l2239. doi: https://doi.org/10.1136/bmj.l2239

Every-Palmer S, Howick J. How evidence-based medicine is failing due to biased trials and selective publication. Journal of Evaluation in Clinical Practice. 2014;20(6):908–14. doi: https://doi.org/10.1111/jep.12147